Lux Ventures
Venture capitalActively deployingNew York · 3 people tracked
Find your way into Lux Ventures
Fund manager profile
Lux Ventures is a venture fund manager based in New York. SEC filings show 8 venture funds on record, most recently Lux Ventures VIII-A, L.P. ($35.5M offering) filed September 2026.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 3 people
from public directoriesWhat they invest in
from 5 of 5 portfolio companiesDeep Tech ×3Biotech ×2Medical Devices ×2AI & Machine Learning ×1Construction Tech ×1Consumer ×1Data & Infrastructure ×1Enterprise Software ×1
HQs:United States×5
Investments · 5 tracked
founders shown can be your intro path
Everspin Technologies manufactures Magnetoresistive Random Access Memory (MRAM) products for mission-critical applications requiring high reliability, low power consumption, and fast access.
Deep TechHardwareSemiconductorsChandler, US
PHILLIP LOPRESTI(Executive Officer, Director)inROBERT SCHUCH(Executive Officer)Sanjeev Aggarwal(President, Chief Executive Officer and Director)in
BoardLARRY FINCH(Director)STEPHEN SOCOLOF(Director)PETER HEBERT(Director)
Co-investorsEPIC VENTURESLux CapitalDraper Fisher Jurvetson (DFJ)GLOBALFOUNDRIES
Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments.
AI & Machine LearningBiotechData & InfrastructureDeep TechMedical DevicesSalt Lake City, US
Chris Gibson(Co-founder, Chairman of the Board)inBlake C. Borgeson(Executive Officer, Director)inChristopher C. Gibson(Executive Officer, Director)Dean Y. Yi(Executive Officer, Director)
Co-investorsDCVC (Data Collective)Lux CapitalBaillie GiffordAir Street CapitalAmplify PartnersCatalio Capital Management, LP+14 more
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.
BiotechDeep TechMedical DevicesSouth San Francisco, US
Tim Lu(Co-Founder and Chief Executive Officer)inPhilip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYvonne Li(Executive Officer)inJames Collins(Director)
BoardDonald Tang(Director)
Co-investorsEvolution VC PartnersFlucas VenturesLifeforce CapitalLux CapitalMenlo VenturesNew Enterprise Associates (NEA)+10 more
HealthtechPalo Alto, US
Daniel Hawkins(Executive Officer, Director)F.T. Jay Watkins(Director)
Board seatPeter Hebert· per SEC Form D · $100M raise · filed Oct 2020
Co-investorsSonder Futures
Matterport provides 3D imaging and digital twin technology for real estate, construction, facilities management, and property marketing, enabling clients to visualize spaces remotely and make data-driven decisions.
Construction TechConsumerEnterprise SoftwarePropTechSunnyvale, US
Matt Bell(Founder)inDavid Gausebeck(Founder/CTO)inMichael Beebe(Chief Operating Officer)inRJ Pittman(CEO)inWillian Brown(Chief Executive Officer)
Board seatPeter Hebert· per SEC Form D · $52.4M raise · filed Jul 2020
Co-investorsBrighter CapitalCapria VenturesDCM VenturesFelicis VenturesGoresiGlobe Partners+16 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
IPOs and acquisitions across the tracked portfolioEverspinNASDAQ: MRAMRecursion (NASDAQ: RXRX)NASDAQ: RXRXSenti BiosciencesNASDAQ: SNTI
Portfolio news
latest coverage across their companiesEverspin · investing.com · Aug 18, 2026
Senti Biosciences · kalkine.com.au · Jul 31, 2026
Matterport · pathfounders.com · Jul 14, 2026
Fund performance · per public LP disclosures
as of Jun 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Lux Ventures VIII, L.P.LPs: California Public Employees' Retirement System | 2023 | — | — | 1.41x | 0.00x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
IPO stake values · per SEC filings · 2
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Recursion (NASDAQ: RXRX) | 11.3% | $18.00 | Apr 2021 | $309.4M |
| Everspin | 7.0% | $8.00 | Oct 2016 | $7M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- Where is Lux Ventures located?
- Lux Ventures is headquartered in New York, US.